Cargando…
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates
HIV-1 infection can be controlled by anti-retroviral drug therapy, but this is a lifetime treatment and the virus remains latent and rapidly rebounds if therapy is stopped. HIV-1-infected individuals under this drug regimen have increased rates of cancers, cardiovascular diseases, and autoimmunity d...
Autores principales: | Flamar, Anne-Laure, Bonnabau, Henri, Zurawski, Sandra, Lacabaratz, Christine, Montes, Monica, Richert, Laura, Wiedemann, Aurelie, Galmin, Lindsey, Weiss, Deborah, Cristillo, Anthony, Hudacik, Lauren, Salazar, Andres, Peltekian, Cécile, Thiebaut, Rodolphe, Zurawski, Gerard, Levy, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267996/ https://www.ncbi.nlm.nih.gov/pubmed/30500852 http://dx.doi.org/10.1371/journal.pone.0207794 |
Ejemplares similares
-
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques
por: Zurawski, Gerard, et al.
Publicado: (2016) -
Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo
por: Flamar, Anne-Laure, et al.
Publicado: (2015) -
P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009) -
S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
por: Loof, N, et al.
Publicado: (2009) -
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
por: Thiébaut, Rodolphe, et al.
Publicado: (2019)